Evidence map›Paper›PMID 33774737›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2021

Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers.

Juan Riestra-Ayora, Joaquin Yanes-Diaz, Jonathan Esteban-Sanchez, Cristina Vaduva, Cristina Molina-Quiros, Alba Larran-Jimenez, Eduardo Martin-Sanz

Open access · bronzeAbstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 6 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 6 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  3. Long COVID, audiovestibular symptoms and persistent chemosensory dysfunction: a systematic review of the current evidence.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2022
    Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Observational
  16. Systematic Review of the Prevalence of Long COVID.Open forum infectious diseases · 2023
    Article
  17. Review
  18. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juan Riestra-AyoraDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain. juan.riestra@hotmail.com.ORCID http://orcid.org/0000-0003-0297-2711
Joaquin Yanes-DiazDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Jonathan Esteban-SanchezDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Cristina VaduvaDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Cristina Molina-QuirosDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Alba Larran-JimenezDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Eduardo Martin-SanzDepartment of Otolaryngology-Head and Neck Surgery, University Hospital of Getafe, Crta Toledo Km 12,500, Madrid, Spain.
Hospital Universitario de Getafe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe study aimed to determine the incidence and long-term evolution of COVID-related olfactory (OD) and gustatory (GD) dysfunction, the recovery timeline, and the association with other symptoms. The secondary objective was to identify the predictive clinical factors for the evolution of these symptoms.

methodsA prospective case-control study was conducted from March 15 to October 15, 2020, in health workers with COVID-19 related symptoms in a tertiary care hospital. 320 patients were included after 6 months of follow-up: 195 in the case group and 125 in the control group. Olfactory dysfunction (OD), dysosmia, and gustatory dysfunction (GD) onset and recovery rate after 6 months follow-up are analyzed in both groups.

resultsThere were 125 (64.1%) in case group patients with OD and 118 (60.5%) with GD. Total or partial recovery OD and GD was found in 89%, mainly in the first 2 months. In the control group, there were 14 (11.2%) patients with OD and 33 (26.4%) patients with GD, with 100% of total/partial recovery.

conclusionIn both groups, OD and GD showed high-resolution rates during the first two months after the onset of symptoms. Nevertheless, 11% of the case group patients did not show any recovery, and the partial resolution was present in 30% of our patients, at the 6 months follow-up. We found a high correlation between OD and GD, both in the appearance of symptoms and in their recovery. Nasal obstruction and dyspnea have been identified as risk factors for the persistence of symptoms.

Indexed as

COVID-19Olfaction DisordersCase-Control StudiesFollow-Up StudiesHumansSARS-CoV-2Taste DisordersCOVID-19DysosmiaGustatory perceptionOlfactory perceptionQuality of lifeSARS-CoV-2

Identifiers

PMID33774737
PMCPMC8004560
OpenAlexW3151825803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.